Showing results (251-260 of 382) with videos related to

Sort By:
Pageof 39
Cancer Research|April 21, 2011
Common and overlapping oncogenic pathways contribute to the evolution of acute myeloid leukemiasBrynn T Kvinlaug, Wai-In Chan, Lars Bullinger, et al.
Blood|November 28, 2022
Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic strokeChristopher M Arends, Thomas G Liman, Paulina M Strzelecka, et al.
Leukemia|August 17, 2023
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
Cell|June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cellsClaudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Blood|February 14, 2019
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrationsJonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, et al.
Blood|May 25, 2013
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemiaJan Krönke, Lars Bullinger, Veronica Teleanu, et al.
Haematologica|October 15, 2020
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1Eugen Tausch, Philipp Beck, Richard F Schlenk, et al.
Blood|October 11, 2012
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterationsJennifer Edelmann, Karlheinz Holzmann, Florian Miller, et al.
Leukemia|January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agentsRabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
Pageof 39